PTN vs ENTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENTX Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Entera Bio Ltd. Ordinary Shares (ENTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while PTN counters with relative strength in Valuation. Fundamentally, PTN trades at 42.9x Forward P/E with -65.7% operating margin (-80.1% YoY revenue) versus ENTX at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENTX sits in CONSOLIDATION (32nd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PTN Revenue | ENTX Revenue | PTN Op. Margin | ENTX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $60M | N/A | 59.3% | N/A | PTN |
| FY2020 | $0M | $0M | -20007.6% | -3059.7% | ENTX |
| FY2021 | N/A | $0M | N/A | -2139.6% | ENTX |
| FY2022 | $0M | $0M | -2491.6% | -9714.2% | PTN |
| FY2023 | $0M | N/A | -668.7% | N/A | PTN |
| FY2024 | $0M | $0M | -501.0% | -5295.6% | PTN |
| FY2025 | N/A | $0M | N/A | -27450.0% | ENTX |
| FY2026 | $10M | N/A | -65.7% | N/A | PTN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PTN | ENTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $11.1M | $541.6M | Larger Scale | ENTX |
| Trailing P/E Ratio Valuation | 42.9x | N/M | Lower Multiple | PTN |
| Forward P/E Ratio Valuation | 42.9x | N/M | Lower Multiple | PTN |
| Revenue Growth (YoY) Growth | -80.1% | -100.0% | Higher Growth | PTN |
| Operating Margin (TTM) Profitability | -65.7% | 0.0% | Higher Margin | ENTX |
| Net Profit Margin Profitability | -63.5% | 0.0% | Higher Margin | ENTX |
| Return on Equity (ROE) Capital Efficiency | -877.5% | -20.3% | Higher ROE | ENTX |
| 52-Week Range Position Momentum | 6% ($5โ$31) | 64% ($1โ$4) | Stronger Trend | ENTX |
| Beta / 30D Volatility Risk Regime | 0.87ฮฒ ยท 106% Vol | 1.07ฮฒ ยท 46% Vol | Lower Realized Risk | ENTX |
| Unified Institutional Score Composite Signal | 31.5 / 100 (SELL) | 53.5 / 100 (HOLD) | Higher Composite | ENTX |